Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM5 | P41594 | 2/20 | 0.38 |
| ▸ | PTPN11 | Q06124 | 12/20 | 0.35 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.35 |
| ▸ | CNR2 | P34972 | 1/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.35 |
| ▸ | MAPK3 | P27361 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | NUDT1 | P36639 | 2/20 | 0.34 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31727794 | 0.81 | GRM5 (0.32) | GRM5GRM4CNR2 | |
| SCHEMBL31729246 | 0.75 | DGAT1 (0.39) | PTPN11CNR2KCNH2MAPK3MAPK1 | |
| SCHEMBL31729200 | 0.73 | DGAT1 (0.39) | PTPN11NUDT1DGAT1 | |
| SCHEMBL31728602 | 0.65 | CNR2 (0.49) | PTPN11CNR2DGAT1 | |
| SCHEMBL31727962 | 0.63 | PIK3CD (0.35) | GRM5PTPN11DGAT1 | |
| SCHEMBL31727998 | 0.62 | MAP4K4 (0.49) | PTPN11CNR2DGAT1 | |
| SCHEMBL31727873 | 0.61 | SMN1; SMN2 (0.40) | PTPN11MAPK1NUDT1DGAT1 | |
| SCHEMBL31728633 | 0.61 | MAP4K4 (0.41) | MAPK1NUDT1DGAT1 | |
| SCHEMBL16925172 | 0.61 | PTPN11 (0.70) | PTPN11KCNH2MAPK3MAPK1 | |
| SCHEMBL16925395 | 0.60 | PTPN11 (0.76) | PTPN11KCNH2MAPK3MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025235874-A1 | HETEROCYCLICS AS EGFR INHIBITORS | SCHRÖDINGER, INC. (US) | 2025-11-13 | — | — | WO | disclosed |